NCT02430779View on ClinicalTrials.gov

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 1, 2020

Study Completion Date

January 1, 2021

Conditions
Renal Pelvic and Ureteral Neoplasms
Interventions
PROCEDURE

rreversible electroporation (IRE)

Irreversible Electroportion For Unresectable Renal Pelvic and Ureteral Neoplasms guide with ultrasound or/and CT.

DEVICE

NanoKnife

Trial Locations (1)

510000

Biological treatment center in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02430779 - Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms | Biotech Hunter | Biotech Hunter